[Form 4] Amplitude, Inc. Insider Trading Activity
Erica Schultz, a director of Amplitude, Inc. (AMPL), reported transactions on 09/15/2025: She exercised an early-exercisable option to purchase 10,000 shares at a $4.19 exercise price and immediately sold 10,000 shares pursuant to a pre-established 10b5-1 trading plan. The sale generated a weighted average sale price of $11.0633 per share, with execution prices ranging from $10.85 to $11.31. Following these transactions, Schultz beneficially owned 79,500 shares subject to outstanding options and 107,406 shares of Class A common stock.
The option vests monthly beginning 12/10/2020 and fully vested on the fourth anniversary; the sale was executed under the 10b5-1 plan adopted 03/12/2025.
- Exercise of in-the-money options at $4.19 demonstrates leverage capture versus market prices
- Sale executed under a 10b5-1 trading plan, indicating pre-established trading intent and reduced timing concerns
- Transparent disclosure of weighted average sale price and price ranges ($10.85–$11.31)
- Insider sold 10,000 shares, reducing her immediate shareholdings in AMPL
- Reported beneficial ownership decreased from 117,406 to 107,406 Class A shares following the sale
Insights
TL;DR: Director exercised in-the-money options and sold the exercised shares under a 10b5-1 plan, realizing roughly $70k in gross proceeds.
The director exercised 10,000 options with a $4.19 strike and sold the same number of shares at a weighted average price of $11.0633, indicating a per-share gross gain of about $6.87 before taxes and fees. The sale was executed under a 10b5-1 plan adopted March 12, 2025, and prices ranged $10.85–$11.31. Post-transaction beneficial ownership includes 107,406 Class A shares and 79,500 optioned shares.
TL;DR: Transaction follows standard governance practices: early exercise plus planned sale under a 10b5-1 plan.
The filing discloses that the sale was pursuant to a documented 10b5-1 plan, reducing concerns about opportunistic insider timing. The reporting was executed by an attorney-in-fact and properly signed. The remaining beneficial ownership and outstanding options are disclosed, with vesting schedule noted for transparency.